EPIX Pharmaceuticals Announces FDA Approval of Vasovist ... WELT ONLINE, Germany - "Vasovist is a first-in-class contrast agent with several unique characteristics that we believe will allow it to become a market leader in the United ... |
Read More...
[Source: Turkey Property Market - Google News ]
Hiç yorum yok:
Yorum Gönder